JP2022529806A5 - - Google Patents
Info
- Publication number
- JP2022529806A5 JP2022529806A5 JP2021562811A JP2021562811A JP2022529806A5 JP 2022529806 A5 JP2022529806 A5 JP 2022529806A5 JP 2021562811 A JP2021562811 A JP 2021562811A JP 2021562811 A JP2021562811 A JP 2021562811A JP 2022529806 A5 JP2022529806 A5 JP 2022529806A5
- Authority
- JP
- Japan
- Prior art keywords
- same
- compound according
- different
- groups
- item
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962838206P | 2019-04-24 | 2019-04-24 | |
| US62/838,206 | 2019-04-24 | ||
| PCT/US2020/029066 WO2020219417A1 (en) | 2019-04-24 | 2020-04-21 | Galactose-linked multimeric glycomimetic inhibitors of e-selectins, galectin-3, and/or cxcr4 chemokine receptors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022529806A JP2022529806A (ja) | 2022-06-24 |
| JP2022529806A5 true JP2022529806A5 (https=) | 2023-04-24 |
Family
ID=70680623
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021562811A Pending JP2022529806A (ja) | 2019-04-24 | 2020-04-21 | Ｅ－セレクチン、ガレクチン－３、および／またはｃｘｃｒ４ケモカイン受容体のガラクトース連結型多量体糖模倣性阻害剤 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230079833A1 (https=) |
| EP (1) | EP3958978A1 (https=) |
| JP (1) | JP2022529806A (https=) |
| KR (1) | KR20220012246A (https=) |
| CN (1) | CN114340736A (https=) |
| AU (1) | AU2020263266A1 (https=) |
| BR (1) | BR112021021244A2 (https=) |
| CA (1) | CA3136661A1 (https=) |
| WO (1) | WO2020219417A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3122321A1 (en) | 2018-12-27 | 2020-07-02 | Glycomimetics, Inc. | Galectin-3 inhibiting c-glycosides |
| ES3063748T3 (en) * | 2019-07-31 | 2026-04-20 | Crescent Biopharma Inc | E-selectin antagonists for use in enhancing the survival of reconstituted, bone marrow-depleted hosts |
| US20230147312A1 (en) | 2020-03-27 | 2023-05-11 | Glycomimetics, Inc. | Treatment of acute respiratory distress syndrome and related conditions with antagonists of e-selectin |
| WO2021247396A1 (en) | 2020-05-31 | 2021-12-09 | Magnani John L | Compounds and methods for reduction of cancer cell burden and protection of normal hematopoiesis |
| AU2021292458A1 (en) | 2020-06-14 | 2023-01-19 | GlycoMimetics | Compositions and methods for overcoming microenvironment-mediated resistance via e-selectin targeting |
| US20240269157A1 (en) | 2021-08-03 | 2024-08-15 | Glycomimetics, Inc. | Compositions and methods for overcoming microenvironment-mediated resistance via e-selectin targeting |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003097658A2 (en) | 2002-05-16 | 2003-11-27 | Glycomimetics, Inc. | Compounds and methods for inhibiting selectin-mediated function |
| SE0401300D0 (sv) | 2004-05-21 | 2004-05-21 | Forskarpatent I Syd Ab | Novel Galactoside Inhibitors of Galectins |
| PL2264043T3 (pl) | 2005-09-02 | 2018-04-30 | Glycomimetics, Inc. | Heterobifunkcyjne inhibitory pan-selektyny |
| EP2074132B1 (en) | 2006-10-12 | 2013-05-15 | GlycoMimetics, Inc. | Glycomimetic replacements for hexoses and n-acetyl hexosamines |
| ES2543063T3 (es) | 2008-05-16 | 2015-08-14 | Galecto Biotech Ab | Nueva síntesis de inhibidores de galactósidos |
| KR102055958B1 (ko) | 2011-12-22 | 2019-12-13 | 글리코미메틱스, 인크. | E-셀렉틴 길항제 화합물, 조성물, 및 이용 방법 |
| CA2888527A1 (en) * | 2012-10-31 | 2014-05-08 | Glycomimetics, Inc. | E-selectin antagonists compounds and methods of use |
| JP6689854B2 (ja) | 2014-12-03 | 2020-04-28 | グリコミメティクス， インコーポレイテッド | Ｅ−セレクチンおよびｃｘｃｒ４ケモカイン受容体のヘテロ二官能性阻害剤 |
| AU2017341065B2 (en) * | 2016-10-07 | 2023-04-06 | Crescent Biopharma, Inc. | Highly potent multimeric E-selectin antagonists |
-
2020
- 2020-04-21 JP JP2021562811A patent/JP2022529806A/ja active Pending
- 2020-04-21 CA CA3136661A patent/CA3136661A1/en active Pending
- 2020-04-21 US US17/605,107 patent/US20230079833A1/en not_active Abandoned
- 2020-04-21 WO PCT/US2020/029066 patent/WO2020219417A1/en not_active Ceased
- 2020-04-21 CN CN202080046293.0A patent/CN114340736A/zh active Pending
- 2020-04-21 AU AU2020263266A patent/AU2020263266A1/en not_active Abandoned
- 2020-04-21 BR BR112021021244A patent/BR112021021244A2/pt unknown
- 2020-04-21 KR KR1020217037835A patent/KR20220012246A/ko not_active Abandoned
- 2020-04-21 EP EP20725311.3A patent/EP3958978A1/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022529806A5 (https=) | ||
| JP2020510054A5 (https=) | ||
| JP2021527125A5 (https=) | ||
| JP2021508697A5 (https=) | ||
| JP2024050527A5 (https=) | ||
| JP2021088610A5 (https=) | ||
| JP2019518766A5 (https=) | ||
| JP2021519783A5 (https=) | ||
| JP2024504932A5 (https=) | ||
| JP2019529518A5 (https=) | ||
| RU2020115095A (ru) | Пиридиновые, пиразиновые и триазиновые соединения в качестве аллостерических ингибиторов shp2 | |
| JP2022544714A5 (https=) | ||
| JP2024512154A5 (https=) | ||
| JP2020528889A5 (https=) | ||
| JP2019504898A5 (https=) | ||
| JP2021523159A5 (https=) | ||
| JP2012532112A5 (https=) | ||
| JP2017500334A5 (https=) | ||
| JP2017536395A5 (https=) | ||
| JP2022533069A5 (https=) | ||
| JP2009524691A5 (https=) | ||
| JP2016515096A5 (https=) | ||
| JP2005505506A5 (https=) | ||
| JP2003529537A5 (https=) | ||
| JP2009534405A5 (https=) |